Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

GIS Software, Hardware, and Sources of GIS Data01:23

GIS Software, Hardware, and Sources of GIS Data

777
A Geographic Information System (GIS) combines specialized software and hardware to effectively manage, analyze, and present spatial and related data. GIS software includes critical functionalities such as a user interface for easy navigation, database management tools for handling spatial and attribute data, and data retrieval features for efficient access. Analytical tools transform raw data into insights, while display functions produce maps and reports in various formats for effective...
777
Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

639
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
639
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

787
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
787
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.0K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.0K
Data Reporting and Recording01:24

Data Reporting and Recording

5.4K
Reporting and recording are crucial in data documentation. The timely, thorough, and accurate documentation of facts is essential when recording patient data. Failure to record findings during an assessment or interpretation of a problem will result in loss of information and make the patient document unreliable. The reader is left with general impressions if the information is not specific. A recording is documenting data of the individual's health information in a traceable, secure, and...
5.4K
How Data are Classified: Numerical Data00:59

How Data are Classified: Numerical Data

37.2K
Data that are countable or measurable in specific units are called numerical or quantitative data. Quantitative data are always numbers. Quantitative data are the result of counting or measuring the attributes of a population. Amount of money, pulse rate, weight, number of people living in a town, and number of students who opt for statistics are examples of quantitative data.
Quantitative data may be either discrete or continuous. All quantitative data that take on only specific numerical...
37.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emergence of Escherichia coli Hybrid Pathotype ETEC/STEC: A Macroepidemiological Approach of Molecular Characterization in the United States Swine Population.

Transboundary and emerging diseases·2026
Same author

Rediscovery of a seventh sense: humans produce, perceive, and process ultrasound.

Frontiers in neuroscience·2026
Same author

Pharmaceutical pricing and reimbursement information (PPRI): evolution and impact of a policy network over two decades.

Journal of pharmaceutical policy and practice·2026
Same author

Influence of Micro-Nanostructured Anatase-Coated SLA Titanium on Macrophage Behavior.

Journal of functional biomaterials·2026
Same author

Price determinants and pricing policies concerning potentially innovative health technologies: a scoping review.

The European journal of health economics : HEPAC : health economics in prevention and care·2025
Same author

Harmonic vowels and neural dynamics: MEG evidence for auditory resonance integration in singing.

Frontiers in neuroscience·2025

Related Experiment Video

Updated: Jan 27, 2026

Objectification of Tongue Diagnosis in Traditional Medicine, Data Analysis, and Study Application
05:56

Objectification of Tongue Diagnosis in Traditional Medicine, Data Analysis, and Study Application

Published on: April 14, 2023

3.2K

Assessing Data Sources for Medicine Price Studies.

Sabine Vogler1, Peter Schneider1

  • 1WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies,Pharmacoeconomics Department,Gesundheit Österreich GmbH (GÖG / Austrian Public Health Institute),Vienna,Austria.

International Journal of Technology Assessment in Health Care
|March 30, 2019
PubMed
Summary

A new framework, Re-ADAPT, guides the selection of medicine price data sources for pharmacoeconomic research. It assesses reliability, accessibility, timeliness, geographic relevance, and pharmaceutical coverage for evidence-based data selection.

Keywords:
AssessmentMedicine pricesMethodsPrice databaseSelection criteria

More Related Videos

Fixed Target Serial Data Collection at Diamond Light Source
06:19

Fixed Target Serial Data Collection at Diamond Light Source

Published on: February 26, 2021

3.8K
IR-TEx: An Open Source Data Integration Tool for Big Data Transcriptomics Designed for the Malaria Vector Anopheles gambiae
08:22

IR-TEx: An Open Source Data Integration Tool for Big Data Transcriptomics Designed for the Malaria Vector Anopheles gambiae

Published on: January 15, 2020

6.6K

Related Experiment Videos

Last Updated: Jan 27, 2026

Objectification of Tongue Diagnosis in Traditional Medicine, Data Analysis, and Study Application
05:56

Objectification of Tongue Diagnosis in Traditional Medicine, Data Analysis, and Study Application

Published on: April 14, 2023

3.2K
Fixed Target Serial Data Collection at Diamond Light Source
06:19

Fixed Target Serial Data Collection at Diamond Light Source

Published on: February 26, 2021

3.8K
IR-TEx: An Open Source Data Integration Tool for Big Data Transcriptomics Designed for the Malaria Vector Anopheles gambiae
08:22

IR-TEx: An Open Source Data Integration Tool for Big Data Transcriptomics Designed for the Malaria Vector Anopheles gambiae

Published on: January 15, 2020

6.6K

Area of Science:

  • Health Economics
  • Pharmaceutical Policy
  • Data Science

Background:

  • No standardized methodology exists for evaluating medicine price data sources.
  • Accurate price data is crucial for robust pharmacoeconomic research and policy decisions.

Purpose of the Study:

  • To develop and validate a framework for assessing the feasibility of medicine price data sources.
  • To provide practical guidance for selecting appropriate data for pharmacoeconomic studies.

Main Methods:

  • A targeted literature review identified key dimensions for medicine price comparisons.
  • Expert review and case studies were used to refine and test the framework's feasibility.

Main Results:

  • The Re-ADAPT framework outlines criteria including reliability, sustainability, accessibility, timeliness, geographic relevance, and pharmaceutical coverage.
  • Case studies confirmed the framework's utility, though interdependencies between criteria were noted.

Conclusions:

  • The Re-ADAPT framework offers practical guidance for selecting medicine price data sources.
  • It aims to enhance the care, balance, and evidence base of data selection in pharmacoeconomic studies.